Clarus Co. (NASDAQ:CLAR – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 15th, there was short interest totalling 1,400,000 shares, a drop of 8.5% from the August 31st total of 1,530,000 shares. Approximately 4.8% of the shares of the company are short sold. Based on an average daily volume of 372,300 shares, the days-to-cover ratio is currently 3.8 days.
Insider Transactions at Clarus
In related news, Chairman Warren B. Kanders acquired 200,000 shares of the company’s stock in a transaction that occurred on Friday, September 6th. The shares were acquired at an average price of $4.19 per share, with a total value of $838,000.00. Following the acquisition, the chairman now owns 4,045,527 shares of the company’s stock, valued at approximately $16,950,758.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Clarus news, Chairman Warren B. Kanders acquired 30,000 shares of the business’s stock in a transaction dated Monday, September 9th. The stock was bought at an average price of $4.05 per share, with a total value of $121,500.00. Following the completion of the acquisition, the chairman now owns 4,075,527 shares of the company’s stock, valued at $16,505,884.35. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Warren B. Kanders acquired 200,000 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were bought at an average cost of $4.19 per share, with a total value of $838,000.00. Following the completion of the acquisition, the chairman now directly owns 4,045,527 shares in the company, valued at approximately $16,950,758.13. The disclosure for this purchase can be found here. Corporate insiders own 22.40% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of CLAR. Deprince Race & Zollo Inc. increased its stake in shares of Clarus by 2.7% during the second quarter. Deprince Race & Zollo Inc. now owns 982,427 shares of the company’s stock valued at $6,612,000 after purchasing an additional 25,495 shares in the last quarter. Sei Investments Co. purchased a new stake in shares of Clarus in the 2nd quarter worth approximately $459,000. First Eagle Investment Management LLC increased its position in Clarus by 3.6% during the 2nd quarter. First Eagle Investment Management LLC now owns 547,578 shares of the company’s stock valued at $3,685,000 after buying an additional 18,848 shares in the last quarter. Old West Investment Management LLC raised its position in shares of Clarus by 8.2% in the 2nd quarter. Old West Investment Management LLC now owns 115,652 shares of the company’s stock worth $778,000 after purchasing an additional 8,800 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in Clarus by 22.8% during the 2nd quarter. Dimensional Fund Advisors LP now owns 791,275 shares of the company’s stock valued at $5,325,000 after purchasing an additional 146,766 shares during the last quarter. 90.30% of the stock is owned by hedge funds and other institutional investors.
Clarus Stock Down 6.2 %
Clarus (NASDAQ:CLAR – Get Free Report) last posted its earnings results on Thursday, August 1st. The company reported ($0.06) earnings per share (EPS) for the quarter. Clarus had a net margin of 2.23% and a negative return on equity of 0.75%. The business had revenue of $56.48 million for the quarter, compared to analysts’ expectations of $59.28 million. During the same period last year, the firm posted $0.07 earnings per share. Equities analysts forecast that Clarus will post 0.02 earnings per share for the current year.
Clarus Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Monday, August 19th. Investors of record on Friday, August 9th were paid a $0.025 dividend. The ex-dividend date of this dividend was Friday, August 9th. This represents a $0.10 annualized dividend and a dividend yield of 2.37%. Clarus’s payout ratio is 38.46%.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on CLAR. B. Riley reduced their price target on shares of Clarus from $9.00 to $7.00 and set a “buy” rating on the stock in a research report on Monday, August 5th. Roth Mkm cut Clarus from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $7.50 to $6.00 in a research note on Friday, August 2nd. StockNews.com cut Clarus from a “hold” rating to a “sell” rating in a report on Saturday, August 10th. Finally, Roth Capital cut Clarus from a “strong-buy” rating to a “hold” rating in a research note on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Clarus currently has a consensus rating of “Hold” and a consensus price target of $6.67.
Read Our Latest Stock Report on CLAR
Clarus Company Profile
Clarus Corporation designs, develops, manufactures, and distributes outdoor equipment and lifestyle products in the United States and internationally. The company operates through two segments, Outdoor and Adventure. The Outdoor segment offers apparels, such as shells, insulation, midlayers, pants, and logowear; rock-climbing footwear and equipment, including carabiners, protection devices, harnesses, belay devices, helmets, and ice-climbing gears; technical backpacks and day packs; trekking poles; headlamps and lanterns; gloves and mittens; and skis, ski poles, ski skins, avalanche airbag systems, avalanche transceivers, shovels, and probes.
Further Reading
- Five stocks we like better than Clarus
- Find and Profitably Trade Stocks at 52-Week Lows
- Why Lennar Stock Could Be the Best Play in the Housing Market
- With Risk Tolerance, One Size Does Not Fit All
- 2 Energy Stocks Fueling the AI Datacenter Boom
- NYSE Stocks Give Investors a Variety of Quality Options
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Clarus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarus and related companies with MarketBeat.com's FREE daily email newsletter.